Cytori Therapeutics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
26,177.00
37,368.00
18,744.00
22,046.00
22,686.00
12,634
Depreciation, Depletion & Amortization
1,630.00
779.00
1,093.00
1,182.00
2,151.00
2,004
Other Funds
221.00
2,262.00
1,623.00
1,774.00
-
313
Funds from Operations
32,462.00
30,694.00
21,771.00
18,761.00
17,091.00
10,943
Changes in Working Capital
2,101.00
364.00
1,303.00
772.00
1,037.00
1,032
Net Operating Cash Flow
34,563.00
30,330.00
20,468.00
19,533.00
18,128.00
11,975
Capital Expenditures
519.00
1,019.00
624.00
67.00
1,496.00
Sale of Fixed Assets & Businesses
5.00
-
11.00
131.00
113.00
Net Investing Cash Flow
3,686.00
1,343.00
613.00
64.00
1,383.00
Cash Dividends Paid - Total
-
-
75.00
-
-
Issuance/Reduction of Debt, Net
2,952.00
1,962.00
9,186.00
-
4,720.00
Net Financing Cash Flow
20,772.00
30,874.00
20,797.00
17,609.00
16,815.00
Net Change in Cash
10,211.00
884.00
284.00
1,778.00
2,685.00
Free Cash Flow
35,082.00
31,094.00
21,079.00
19,600.00
19,624.00
Other Sources
5,000.00
76.00
-
-
-
Change in Capital Stock
18,041.00
35,098.00
31,681.00
19,383.00
21,535.00
Exchange Rate Effect
106.00
85.00
-
82.00
11.00
Other Uses
800.00
400.00
-
-
-
About Cytori Therapeutics
View Profile
